Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Downgrades Globus Medical to Hold

Needham Downgrades Globus Medical to Hold

Needham analyst David Saxon downgrades Globus Medical (NYSE:GMED) from Buy to Hold.

byBenzinga Newsdesk

February 10, 2023

1 minute read

Needham analyst David Saxon downgrades Globus Medical (NYSE:GMED) from Buy to Hold.

TD Securities Upgrades Canadian Natural Res to Action List Buy, Lowers Price Target to C$89

By Benzinga Newsdesk

September 29, 9:35 AM

TD Securities analyst Menno Hulshof upgrades Canadian Natural Res (TSX:CNQ) from Buy to Action List Buy and lowers the price target from C$92 to C$89.

TSX:CNQ

Is Apple About To Disappoint Investors With Q2 Print? Analyst Flags 2 Factors Weakening iPhone Maker

By Shanthi Rexaline

April 16, 8:14 AM

Needham now estimates second-quarter sales of $90.8 billion, marking a 4% year-over-year drop.

AAPL

Homebuilder KB Home’s Q3: Earnings Beat, 14% Topline Decline, Lower Average Selling Price & More

By Shivani Kumaresan

September 21, 5:57 AM

KB Home (NYSE: KBH) reported a third-quarter FY23 sales decline of 13.9% year-on-year to $1.59 billion,

KBH

Analyst Ratings

Expert Ratings for e.l.f. Beauty

By Benzinga Insights

June 12, 5:02 PM

Over the past 3 months, 18 analysts have published their opinion on e.l.f. Beauty (NYSE:ELF) stock. These analysts…

ELF

Needham Downgrades Globus Medical to Hold

Related Posts

TD Securities Upgrades Canadian Natural Res to Action List Buy, Lowers Price Target to C$89

Is Apple About To Disappoint Investors With Q2 Print? Analyst Flags 2 Factors Weakening iPhone Maker

Homebuilder KB Home’s Q3: Earnings Beat, 14% Topline Decline, Lower Average Selling Price & More

Expert Ratings for e.l.f. Beauty